Geneticist

Huntington Medical Research Institutes is nonprofit, public-benefit organization dedicated to improving health and prolonging life by enhancing knowledge of life processes and disease and developing technology to diagnose and treat diseases. Its developments include the hydrocephalus shunt to treat water-on-the-brain, studies on biomedical applications of laser energy, cancer research, electronic neural rehabilitation technology and applications of medical magnetic resonance imaging and spectroscopy. Huntington Medical Research Institutes was founded in 1952 and operates in five locations in Pasadena, Calif.

Laragen, located in Culver City, CA, is a leading provider of genetic sequencing and genotyping services. They offer a range of services including Sanger sequencing, MiSeq sequencing, mouse genotyping, and fragment analysis, among others. With their expertise in DNA analysis, Laragen is able to troubleshoot failed reactions and provide free repeats to ensure accurate results. They also offer proprietary chemistry for difficult templates and provide a quick turnaround time for sequencing and genotyping samples. At Laragen, they understand the importance of high-quality DNA templates for successful sequencing. They recommend using their recommended DNA prep kit and ensuring the correct primer concentration to avoid sequencing failures. With their state-of-the-art equipment and experienced team, Laragen is able to provide reliable and accurate sequencing results, allowing researchers and scientists to advance their genetic studies and discoveries.Generated from the website

MiraDx, located in Los Angeles, CA, is a pioneering company dedicated to advancing personalized cancer treatment through innovative genetic research. Co-founded by renowned experts Dr. Frank Slack and Dr. Joanne Weidhaas, the company focuses on tailoring cancer care plans based on individual patient responses and toxicity profiles to improve therapy outcomes. With groundbreaking tests like PROSTOX and PREVIOTOX, MiraDx empowers physicians to assess risks associated with radiation and immune checkpoint inhibitors, enhancing treatment strategies for cancer patients. Their commitment to utilizing novel biomarkers positions them at the forefront of personalized medicine, ultimately aiming to provide safer and more effective cancer care. Generated from the website